References:
1. Takai Y, Misu T, Kaneko K, Chihara N, Narikawa K, Tsuchida S, et al. (2020) Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain: a journal of neurology 143(5):1431-46. doi:10.1093/brain/awaa102
2. Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, et al. (2018) MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. Journal of neuroinflammation 15(1):134. doi: 10.1186/s12974-018-1144-2
3. Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. (2023) Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. The Lancet Neurology 22(3):268-82. doi:10.1016/S1474-4422(22)00431-8
4. Yao T, Zeng Q, Xie Y, Bi F, Zhang L, Xiao B, et al. (2022) Clinical analysis of adult MOG antibody-associated cortical encephalitis. Mult Scler Relat Disord 60:103727. doi: 10.1016/ j. msard.2022.103727
5. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. The Lancet Neurology 10(1):63-74. doi:10.1016/S1474-4422(10)70253-2
6. Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. (2016) A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology 15(4):391-404. doi:10.1016/S1474-4422(15)00401-9
7. Martinez-Hernandez E, Guasp M, Garcia-Serra A, Maudes E, Arino H, Sepulveda M, et al. (2020) Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies. Neurology 94(22): e2302-e10. doi:10.1212/WNL. 0000000000009239
8. Titulaer MJ, Hoftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, et al. (2014) Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Annals of neurology 75(3):411-28. doi:10.1002/ana.24117
9. Ogawa R, Nakashima I, Takahashi T, Kaneko K, Akaishi T, Takai Y, et al. (2017) MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflamm 4(2): e322. doi:10.1212/NXI. 0000000000000322
10. Budhram A, Mirian A, Le C, Hosseini-Moghaddam SM, Sharma M, Nicolle MW. (2019) Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome. J Neurol 266(10):2481-7. doi:10.1007/s00415-019-09440-8
11. Fan S, Xu Y, Ren H, Guan H, Feng F, Gao X, et al. (2018) Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis. Mult Scler Relat Disord 20:144-52. doi:10.1016/ j. msard.2018.01.007
12. Nan D, Zhang Y, Han J, Jin T. (2021) Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis: a case report and review of the literature. Neurol Sci 42(3):847-55. doi:10.1007/ s10072-020-04942-0
13. Perez CA, Agyei P, Gogia B, Harrison R, Samudralwar R. (2020) Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease. Journal of neuroimmunology 339: 577124. doi: 10.1016/j.jneuroim.2019.577124
14. Berek K, Grams A, Uprimny C, Prieschl M, Ramberger M, Unterberger I, et al. (2022) Anti-NMDA receptor encephalitis and MOG-associated demyelination - a case report with long-term follow-up and a systematic review. BMC Neurol 22(1):434. doi:10.1186/s12883-022-02974-x
15. Yang JX, Yang MM, Han YJ, Gao CH, Cao J. (2023) FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures overlaying anti-N-methyl-D-aspartate receptor encephalitis: a case report and literature review. Frontiers in immunology. 14:1149987 doi:10.3389/fimmu.2023.1149987
16. Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, et al. (2011) Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. Journal of neuroinflammation 8:184. doi:10.1186/1742-2094-8-184
17. Ren BY, Guo Y, Han J, Wang Q, Li ZW. (2021) Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination. Front Neurol 12:639265. doi:10.3389/fneur.2021. 639265
18. Valencia-Sanchez, C, Guo Y, Krecke KN, Chen JJ, Redenbaugh V, Montalvo M, Elsbernd PM, Tillema JM, Lopez-Chiriboga S, Budhram A, Sechi E, Kunchok A, Dubey D, Pittock SJ, Lucchinetti CF, and Flanagan EP. (2023) Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Annals of neurology 93, 297-302. doi:10.1002/ana.26549
19. Kunchok A, Flanagan EP, Krecke KN, Chen JJ, Caceres JA, Dominick J, et al. (2021) MOG-IgG1 and co-existence of neuronal autoantibodies. Mult Scler 27(8):1175-86. doi:10.1177/1352458520951046
20. Cherian A, Divya KP, Shetty SC, Kannoth S, Thomas B. (2020) Coexistent MOG, NMDAR, CASPR2 antibody positivity: Triumph over the triumvirate. Mult Scler Relat Disord 46:102468. doi: 10.1016/j.msard.2020.102468
21. Pruss H. (2017) Postviral autoimmune encephalitis: manifestations in children and adults. Curr Opin Neurol 30(3):327-33. doi:10.1097/WCO. 0000000000000445
22. Mariotto S, Ferrari S, Monaco S, Benedetti MD, Schanda K, Alberti D, et al. (2017) Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study. J Neurol 264(12):2420-30. doi.:10.1007/s00415-017-8635-4
23. Brunner C, Lassmann H, Waehneldt TV, Matthieu JM, Linington C. (1989) Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2’,3’-cyclic nucleotide 3’-phosphodiesterase in the CNS of adult rats. J Neurochem 52(1):296-304. doi:10.1111/j.1471-4159. 1989.tb10930.x
24. Mayer MC, Meinl E. (2012) Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more. Therapeutic advances in neurological disorders 5(3):147-59. doi:10.1177/1756285611433772
25. Lipton SA. (2006) NMDA receptors, glial cells, and clinical medicine. Neuron 50(1):9-11. doi: 10.1016/j.neuron.2006.03.026
26. McLeod DS, Woods ML, Kandiah DA. (2011) Immune reconstitution inflammatory syndrome manifesting as development of multiple autoimmune disorders and skin cancer progression. Intern Med J 41(9):699-703. doi: 10.1111/j.1445-5994.2011. 02546.x
27. Clifford DB. (2015) Neurological immune reconstitution inflammatory response: riding the tide of immune recovery. Curr Opin Neurol 28(3):295-301. doi: 10.1097/WCO.0000000000000200
28. Van Obberghen EK, Cohen M, Rocher F, Lebrun-Frenay C. (2017) Multiple immune disorders after natalizumab discontinuation: After the CIRIS, the SIRIS? Rev Neurol (Paris) 173(4):222-4. doi: 10.1016/j.neurol.2017.03.008
29. Vega E, Arrambide G, Olive G, Castillo M, Felipe-Rucian A, Tintore M, et al. (2023) non-ADEM encephalitis in patients with myelin oligodendrocyte glycoprotein antibodies: a systematic review. Eur J Neurol 30(5):1515-27. doi:10.1111/ene.15684
30. Zhou L, ZhangBao J, Li H, Li X, Huang Y, Wang M, et al. (2017) Cerebral cortical encephalitis followed by recurrent CNS demyelination in a patient with concomitant anti-MOG and anti-NMDA receptor antibodies. Mult Scler Relat Disord 18:90-2. doi: 10.1016/j.msard. 2017.09.023
31. Zhou J, Tan W, Tan SE, Hu J, Chen Z, Wang K. (2018) An unusual case of anti-MOG CNS demyelination with concomitant mild anti-NMDAR encephalitis. Journal of neuroimmunology 320:107-10. doi: 10.1016/j.jneuroim.2018.03.019